Utilization of cardiac monitoring tests in women with nonmetastatic breast cancer treated with trastuzumab

Author： Shin Jaekyu   Liang Su-Ying   Hassett Michael J   Phillips Kathryn A   Haas Jennifer S  

Publisher： Future Medicine

ISSN： 1741-0541

Source： Personalized Medicine, Vol.10, Iss.7, 2013-09, pp. : 703-708

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

What factors are predictive of benefit finding in women treated for non‐metastatic breast cancer? A prospective study

By  

PSYCHO-ONCOLOGY (ELECTRONIC), Vol. 24, Iss. 5, 2015-05 ,pp. : 533-539

John Wiley & Sons Inc

Access to resources Recommend Favorite

Psychosocial Intervention for Women with Primary, Non-Metastatic Breast Cancer: A Comparison between Participants and Non-Participants

By  

Psychotherapy and Psychosomatics, Vol. 73, Iss. 5, 2004-07 ,pp. : 276-285

Karger

Access to resources Recommend Favorite

Racial disparities in functional disability among older women with newly diagnosed nonmetastatic breast cancer

By  

CANCER, Vol. 119, Iss. 21, 2013-11 ,pp. : 3839-3846

John Wiley & Sons Inc

Access to resources Recommend Favorite

Assessment of Adjuvant Trastuzumab-Associated Cardiac Toxicity in Korean Patients with Breast Cancer: A Single-Center Analysis

By  

Oncology, Vol. 85, Iss. 4, 2013-09 ,pp. : 228-234

Karger

Access to resources Recommend Favorite

Effectiveness of Trastuzumab (HerceptinTM) in a Patient with Locally Recurrent Breast Cancer after Cardiac Failure Caused by Severe Cytotoxic Pretreatment

By  

Oncology, Vol. 61, Iss. 4, 2001-11 ,pp. : 271-274

Karger

Access to resources Recommend Favorite